2384121-03-1
2384121-03-1
Chemical Structure
Defactinib-d6
Synonym(s): VS-6063-d6; PF-04554878-d6
- CAS No.: 2384121-03-1
- Formula:C20H15D6F3N8O3S
- Molecular Weight:516.53
InChIKey: FWLMVFUGMHIOAA-WFGJKAKNSA-N
SMILES: O=C(NC([2H])([2H])[2H])C1=CC=C(NC2=NC=C(C(F)(F)F)C(NCC3=NC=CN=C3N(C([2H])([2H])[2H])S(=O)(C)=O)=N2)C=C1
Biological Activity: Defactinib-d6 is a deuterium labeled Defactinib (HY-12289). Defactinib is a novel FAK inhibitor with potential antiangiogenic and antineoplastic activities[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Defactinib-d6 | Defactinib-d6 is a deuterium labeled Defactinib (HY-12289). Defactinib is a novel FAK inhibitor with potential antiangiogenic and antineoplastic activities. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Defactinib (Standard) | ≥98% | Defactinib (Standard) is the analytical standard of Defactinib. This product is intended for research and analytical applications. Defactinib (VS-6063; PF-04554878) is a novel FAK inhibitor with potential antiangiogenic and antineoplastic activities. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Defactinib | 99.74% | Defactinib (VS-6063; PF-04554878) is a novel FAK inhibitor with potential antiangiogenic and antineoplastic activities. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
